This contract expires in 355 days (Sep 2, 2027).

LEIDOS BIOMEDICAL RESEARCH INC - HNGR(310)FC GMP3 CAMPAIGN AND OCTET METHOD DEVELOPMENT

PIID: 75N91019F00140Solicitation ID: N02CO7240681

Signed Date: Sep 14, 2019Effective Date: Sep 16, 2019End Date: Closes in 355 days

Award $

$9.2M

Vendor

LEIDOS BIOMEDICAL RESEARCH INC

NAICS

541715

Signed Date

Sep 14, 2019

Key Details

Dollars Obligated

$9.2M

Base & All Options

$10.5M

Awarding Agency

Awarding Sub-Agency

National Institutes of Health

NAICS Code

Parent IDIQ (PIID)

75N91019D00024

Product Service Code

AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Place of Performance

FREDERICK, MD

HNGR(310)FC GMP3 CAMPAIGN AND OCTET METHOD DEVELOPMENT

On Sep 14, 2019, Department of Health and Human Services obligated $9,231,560 to LEIDOS BIOMEDICAL RESEARCH INC for hngr(310)fc gmp3 campaign and octet method development. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). Competition extent: full and open competition. Performance is located in FREDERICK, MD. The contract is scheduled through Sep 2, 2027 — approximately 12 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.